glycopyrrolate has been researched along with aclidinium bromide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaraz, L; Bailey, A; Bowers, K; Donald, D; Edwards, H; Hunt, F; Kindon, N; Pairaudeau, G; Stocks, MJ; Theaker, J; Warner, DJ | 1 |
| Hamaguchi, H; Kontani, T; Koshika, T; Matsushima, Y; Moritomo, A; Nagashima, S; Nagata, H; Takeuchi, M | 1 |
| Asano, T; Fukunishi, Y; Kanda, Y; Kawahara, M; Mizushima, T; Takafuji, A; Takenaga, M; Tanaka, KI; Yamakawa, N; Yamashita, Y | 1 |
| Greening, A; Huisman, E; Karabis, A; Lindner, L; Mocarski, M | 1 |
| Alberti, J; Aparici, M; Beleta, J; Calama, E; Carcasona, C; Gavaldà, A; Miralpeix, M; Montero, JL; Otal, R; Ramos, I; Sentellas, S; Vilella, D | 1 |
| Jones, PW | 1 |
| Calzetta, L; Cazzola, M; Lipsi, R; Matera, MG; Ora, J; Rogliani, P; Segreti, A | 1 |
| Centanni, S; Di Marco, F; Raccanelli, R; Radovanovic, D; Santus, P; Valenti, V | 1 |
| Huisman, EL; Ismaila, AS; Karabis, A; Punekar, YS | 1 |
| Ciciliani, AM; Langguth, P; Wachtel, H | 1 |
| Deas, SD; Huprikar, N | 1 |
| Iwakura, M; Satake, M; Sato, S; Shioya, T; Takahashi, H; Terui, Y; Uemura, S | 1 |
| Lad, R; Rhee, CK; Yoshisue, H | 1 |
6 review(s) available for glycopyrrolate and aclidinium bromide
| Article | Year |
|---|---|
Comparative efficacy of aclidinium versus glycopyrronium and tiotropium, as maintenance treatment of moderate to severe COPD patients: a systematic review and network meta-analysis.
Topics: Bayes Theorem; Bronchodilator Agents; Forced Expiratory Volume; Glycopyrrolate; Humans; Lung; Muscarinic Antagonists; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Recovery of Function; Scopolamine Derivatives; Severity of Illness Index; Tiotropium Bromide; Treatment Outcome; Tropanes | 2013 |
Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
Topics: Clinical Trials as Topic; Delayed-Action Preparations; Glycopyrrolate; Humans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Tiotropium Bromide; Tropanes | 2015 |
Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis.
Topics: Aged; Bayes Theorem; Bronchodilator Agents; Drug Administration Schedule; Female; Forced Expiratory Volume; Glycopyrrolate; Humans; Lung; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinuclidines; Randomized Controlled Trials as Topic; Recovery of Function; Spirometry; Surveys and Questionnaires; Time Factors; Tiotropium Bromide; Treatment Outcome; Tropanes | 2015 |
Dual bronchodilator therapy for chronic obstructive pulmonary disease: evidence for the efficacy and Safety of fixed dose combination treatments in the setting of recent guideline updates.
Topics: Administration, Inhalation; Benzoxazines; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Delayed-Action Preparations; Drug Combinations; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Tiotropium Bromide; Tropanes | 2018 |
Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment.
Topics: Adrenergic beta-2 Receptor Agonists; Behavior; Counseling; Delayed-Action Preparations; Drug Therapy, Combination; Energy Metabolism; Exercise; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolones; Self Efficacy; Terbutaline; Treatment Outcome; Tropanes | 2018 |
Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Asian People; Benzoxazines; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Drug Combinations; Formoterol Fumarate; Glycopyrrolate; Humans; Indans; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Quinolones; Quinuclidines; Tiotropium Bromide; Treatment Outcome; Tropanes | 2019 |
2 trial(s) available for glycopyrrolate and aclidinium bromide
| Article | Year |
|---|---|
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi.
Topics: Administration, Inhalation; Bronchi; Bronchoconstriction; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Glycopyrrolate; Humans; In Vitro Techniques; Male; Middle Aged; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Time Factors; Tiotropium Bromide; Treatment Outcome; Tropanes | 2015 |
Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study.
Topics: Aged; Aged, 80 and over; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Dyspnea; Endpoint Determination; Female; Glycopyrrolate; Humans; Lung; Male; Middle Aged; Plethysmography; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Residual Volume; Respiratory Function Tests; Tropanes | 2015 |
5 other study(ies) available for glycopyrrolate and aclidinium bromide
| Article | Year |
|---|---|
The discovery of new spirocyclic muscarinic M3 antagonists.
Topics: Animals; Drug Evaluation, Preclinical; Hepatocytes; Humans; Microsomes; Rats; Receptor, Muscarinic M3; Spiro Compounds | 2010 |
Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists.
Topics: Animals; Carbamates; Dose-Response Relationship, Drug; Male; Models, Molecular; Molecular Structure; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Structure-Activity Relationship | 2014 |
Chemical modification-mediated optimisation of bronchodilatory activity of mepenzolate, a muscarinic receptor antagonist with anti-inflammatory activity.
Topics: Administration, Inhalation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzilates; Bronchodilator Agents; Dose-Response Relationship, Drug; Mice; Molecular Structure; Pancreatic Elastase; Piperidines; Pulmonary Emphysema; Receptor, Muscarinic M3; Structure-Activity Relationship; Swine | 2019 |
The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
Topics: Acetylcholine; Animals; Bronchoconstriction; Bronchodilator Agents; Glycopyrrolate; Guinea Pigs; Half-Life; Humans; Hydrolysis; Ipratropium; Male; Muscarinic Antagonists; Rats; Rats, Wistar; Scopolamine Derivatives; Species Specificity; Time Factors; Tiotropium Bromide; Tropanes | 2014 |
In vitro dose comparison of Respimat
Topics: Administration, Inhalation; Androstadienes; Benzyl Alcohols; Bronchodilator Agents; Chlorobenzenes; Computer Simulation; Drug Combinations; Dry Powder Inhalers; Equipment Design; Glycopyrrolate; Humans; Hydrodynamics; Lung; Metered Dose Inhalers; Models, Anatomic; Muscarinic Antagonists; Pharynx; Pulmonary Disease, Chronic Obstructive; Respiration; Severity of Illness Index; Tiotropium Bromide; Tropanes | 2017 |